REPLIMUNE

Lobbying client · Massachusetts · filed 2025 to 2026

Biotech

$180,000 Reported spend

4 Filings counted

1 Firms hired

0 Bills named

Spend is reported income plus in-house expenses across 4 filings. 1 further filing on this record was restated by a later amendment and is left out of every total here. Everything on this page is grouped by the client's LDA id (69406), not by name.

Firms hired 1

FARRAGUT PARTNERS LLP $180,000 4 filings

Reported by year 2 years

2026 $60,000 1 filing
2025 $120,000 3 filings

Issues lobbied 1

Health Issues 4

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

Food & Drug Administration (FDA) 3
HOUSE OF REPRESENTATIVES 3
SENATE 3

Recent filings 5 total

1T

FARRAGUT PARTNERS LLP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Jul 20, 2026

View → Q1

FARRAGUT PARTNERS LLP Amended

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $60,000 income · posted Apr 20, 2026

View → Q4

FARRAGUT PARTNERS LLP

4th Quarter (Oct 1 - Dec 31) 2025 · House · Senate · $60,000 income · posted Jan 20, 2026

View → Q3

FARRAGUT PARTNERS LLP

3rd Quarter (July 1 - Sep 30) 2025 · House · Senate · $60,000 income · posted Oct 20, 2025

View → RR

FARRAGUT PARTNERS LLP

3rd Quarter (July 1 - Sep 30) 2025 · posted Oct 20, 2025

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.